WellSIM BioMedical Technologies

WellSIM BioMedical Technologies is a private U.S. life science technology company developing nanofluidic and extracellular-vesicle analysis tools for diagnostics and biomedical research. Its core offering, ExoDot, is a platform for high-sensitivity detection and characterization of extracellular vesicle surface protein markers at single-particle resolution without purification. The company positions its technology for liquid biopsy and non-invasive cancer testing using biofluids such as plasma, urine, and saliva. In addition to platform products, WellSIM appears to offer analytical services built around ExoDot for research and translational applications. Overall, the company is better characterized as a diagnostics and life-science tools platform company than as a therapeutics developer.